Introduction: Transcatheter aortic valve implantation (TAVI) has become an alternative to open surgery in those deemed high risk. The purpose of this study was to evaluate the effectiveness and outcomes of this emerging procedure. We have examined available literature to provide an overview of valve-in-valve implantation using transcatheter heart valves (THVs) in aortic, mitral, pulmonary, tricuspid positions. Methods: A systematic search was conducted using MEDLINE, PubMed, EMBASE, Current Contents Connect, Cochrane library, Google Scholar, Science Direct, and Web of Science. Results: Only 61 studies met full criteria and were included the review. This included 31 studies reporting transcatheter aortic valve-in-valve implantation, mitral v...
ObjectivesWe sought to analyze outcomes of patients with degenerated surgically implanted bioprosthe...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment optio...
Bioprosthetic aortic valve replacement is the treatment of choice for patients over 65 years of age ...
Redo surgery still is the treatment of choice for degenerated bioprosthesis. However, as far as elde...
Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to...
INTRODUCTION: Redo surgery still is the treatment of choice for degenerated bioprosthesis. However, ...
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young ...
Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
AbstractTranscatheter aortic valve replacement (TAVR) has been established as a less invasive altern...
ABSTRACTBackgroundRecent studies have demonstrated the efficacy of the transcatheter valve-in-valve ...
ObjectivesWe sought to analyze outcomes of patients with degenerated surgically implanted bioprosthe...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment optio...
Bioprosthetic aortic valve replacement is the treatment of choice for patients over 65 years of age ...
Redo surgery still is the treatment of choice for degenerated bioprosthesis. However, as far as elde...
Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to...
INTRODUCTION: Redo surgery still is the treatment of choice for degenerated bioprosthesis. However, ...
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young ...
Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
AbstractTranscatheter aortic valve replacement (TAVR) has been established as a less invasive altern...
ABSTRACTBackgroundRecent studies have demonstrated the efficacy of the transcatheter valve-in-valve ...
ObjectivesWe sought to analyze outcomes of patients with degenerated surgically implanted bioprosthe...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...
Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often de...